| Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin JS Choi, YJ Piao, KW Kang Archives of pharmacal research 34, 607-613, 2011 | 241 | 2011 |
| Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats SC Shin, JS Choi, X Li International Journal of Pharmaceutics 313 (1-2), 144-149, 2006 | 222 | 2006 |
| In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans Y Sato, Y Kawashima, H Takeuchi, H Yamamoto International journal of pharmaceutics 275 (1-2), 97-107, 2004 | 178* | 2004 |
| Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin JS Choi, BW Jo, YC Kim European journal of pharmaceutics and biopharmaceutics 57 (2), 313-318, 2004 | 170 | 2004 |
| Supramolecular capsules with gated pores from an amphiphilic rod assembly JK Kim, E Lee, Y Lim, M Lee ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH- 47 (25), 4662, 2008 | 131 | 2008 |
| Enhanced bioavailability of piroxicam via salt formation with ethanolamines HS Gwak, JS Choi, HK Choi International journal of pharmaceutics 297 (1-2), 156-161, 2005 | 128 | 2005 |
| Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone SC Shin, IJ Oh, YB Lee, HK Choi, JS Choi International journal of pharmaceutics 175 (1), 17-24, 1998 | 120 | 1998 |
| Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats X Li, JS Choi International Journal of Pharmaceutics 337 (1-2), 188-193, 2007 | 119 | 2007 |
| Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits SC Shin, JP Bum, JS Choi International journal of pharmaceutics 209 (1-2), 37-43, 2000 | 105 | 2000 |
| Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats SC Shin, JS Choi Anti-cancer drugs 20 (7), 584-588, 2009 | 99 | 2009 |
| An appraisal of drug-drug interactions with green tea (Camellia sinensis) AA Albassam, JS Markowitz Planta medica 234 (06), 496-508, 2017 | 94 | 2017 |
| Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats JS Choi, SC Shin International Journal of Pharmaceutics 292 (1-2), 149-156, 2005 | 88 | 2005 |
| Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol CS Yong, CH Yang, JD Rhee, BJ Lee, DC Kim, DD Kim, CK Kim, JS Choi, ... International journal of pharmaceutics 269 (1), 169-176, 2004 | 88 | 2004 |
| Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits JS Choi, X Li International journal of pharmaceutics 297 (1-2), 1-8, 2005 | 87 | 2005 |
| Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats JS Choi, BW Jo International journal of pharmaceutics 280 (1-2), 221-227, 2004 | 85 | 2004 |
| Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P‐gp inhibition by curcumin CK Lee, SH Ki, JS Choi Biopharmaceutics & drug disposition 32 (4), 245-251, 2011 | 75 | 2011 |
| Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats JS Choi, HK Choi, SC Shin International journal of pharmaceutics 275 (1-2), 165-170, 2004 | 74 | 2004 |
| Effects of quercetin on the pharmacokinetics of etoposide after oral or intravenous administration of etoposide in rats X Li, JS Choi Anticancer research 29 (4), 1411-1415, 2009 | 70 | 2009 |
| Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin YA Cho, W Lee, JS Choi Die Pharmazie-An International Journal of Pharmaceutical Sciences 67 (2 …, 2012 | 69 | 2012 |
| Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 … DH Choi, C Li, JS Choi Journal of Pharmacy and Pharmacology 62 (7), 908-914, 2010 | 68 | 2010 |
